Physician profile
Kay E Midler
NPI 1023063955
$1,305.11
in general payments reported to CMS, 2019-2025
22 companies · $123 in 2025
The $123 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.95 · 2020: $105 · 2021: $287 · 2022: $399 · 2023: $169 · 2024: $150 · 2025: $123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $436.52 | 2019-2023 | |
| Organon LLC | $153.51 | 2021-2025 | Nexplanon |
| Davol INC. | $141.44 | 2022-2023 | Arista Ah Flexitip |
| Mayne Pharma Commercial LLC | $100.39 | 2021-2025 | |
| Hologic Sales and Service, LLC | $75.86 | 2019-2025 | Myosure Tissue Removal Device, Novasure |
| Ethicon US, LLC | $36.81 | 2024 | Ethicon |
| Bayer Healthcare Pharmaceuticals INC. | $36.62 | 2019-2022 | |
| Daiichi Sankyo INC. | $34.87 | 2022 | |
| Exeltis, USA INC. | $31.26 | 2022 | |
| Shield Therapeutics INC | $30.55 | 2024-2025 | |
| Inari Medical, INC. | $28.99 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Merck Sharp & Dohme LLC | $26.59 | 2019 | |
| Pfizer INC. | $25.78 | 2021-2022 | |
| Evofem Biosciences, INC. | $23.07 | 2021 | |
| Intuitive Surgical, INC. | $20.05 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.29 | 2020 | |
| Coopersurgical, INC. | $15.99 | 2020 | |
| Boston Scientific Corporation | $15.22 | 2021 | |
| Sage Therapeutics, LLC | $15.16 | 2024 | |
| Astellas Pharma US INC | $14.21 | 2023 | Veozah |
| Myovant Sciences INC. | $12.40 | 2021 | |
| Allergan, INC. | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kay Midler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.